Home > National Drug Code (NDC) > Treatment Set TS330171

Treatment Set TS330171 - 49288-0725-3 - (Treatment Set TS330171)

Alphabetical Index


Drug Information of Treatment Set TS330171

Product NDC: 49288-0725
Proprietary Name: Treatment Set TS330171
Non Proprietary Name: Treatment Set TS330171
Active Ingredient(s): .002; 160; .0004; 80; 800; 800; 800; .002; 800; .0004; .0004; .002    g/mL; [AU]/mL; g/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; g/mL; [BAU]/mL; g/mL; g/mL; g/mL & nbsp;   Treatment Set TS330171
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS330171

Product NDC: 49288-0725
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 20091218

Package Information of Treatment Set TS330171

Package NDC: 49288-0725-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0725-3)

NDC Information of Treatment Set TS330171

NDC Code 49288-0725-3
Proprietary Name Treatment Set TS330171
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0725-3)
Product NDC 49288-0725
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Treatment Set TS330171
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 20091218
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name ACER NEGUNDO POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; CHENOPODIUM ALBUM POLLEN; CYNODON DACTYLON POLLEN; FESTUCA PRATENSIS POLLEN; LOLIUM PERENNE POLLEN; PHLEUM PRATENSE POLLEN; PLANTAGO LANCEOLATA POLLEN; POA PRATENSIS POLLEN; SALSOLA KALI POLLEN; SORGHUM HALEPENSE POLLEN; ULMUS AMERICANA POLLEN
Strength Number .002; 160; .0004; 80; 800; 800; 800; .002; 800; .0004; .0004; .002
Strength Unit g/mL; [AU]/mL; g/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; g/mL; [BAU]/mL; g/mL; g/mL; g/mL
Pharmaceutical Classes Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS330171


General Information